Men at Risk of HIV: Sexual Sensation Seeking, Sexual Compulsivity and Sexual Risk Behavior Among Australian MSM Who Frequently Present for Post-Exposure Prophylaxis

2016 ◽  
Vol 23 (4) ◽  
pp. 324-341 ◽  
Author(s):  
Mark Danko ◽  
Simone Buzwell ◽  
Michelle Earle
2017 ◽  
Vol 21 (5) ◽  
pp. 1376-1382 ◽  
Author(s):  
Lisa M. Kuhns ◽  
Anna L. Hotton ◽  
John Schneider ◽  
Robert Garofalo ◽  
Kayo Fujimoto

AIDS ◽  
2000 ◽  
Vol 14 (8) ◽  
pp. 1035-1039 ◽  
Author(s):  
Craig R. Waldo ◽  
Ronald D. Stall ◽  
Thomas J. Coates

2018 ◽  
Vol 40 (4) ◽  
pp. 424-431 ◽  
Author(s):  
Marco D.T. Scanavino ◽  
Ana Ventuneac ◽  
Carmita H.N. Abdo ◽  
Hermano Tavares ◽  
Maria L.S. Amaral ◽  
...  

Adolescents ◽  
2021 ◽  
Vol 1 (1) ◽  
pp. 56-69
Author(s):  
Rachel Kovensky ◽  
Atika Khurana ◽  
Sally Guyer ◽  
Leslie D. Leve

Sexual risk behavior in adolescence can lead to adverse health consequences, particularly for female youth. Most interventions focus on imparting knowledge about the consequences of such behaviors, even though little research has examined whether increasing such knowledge results in desired behavioral changes. Further, individual factors such as impulsivity and childhood adversity might moderate this relationship. We examined associations between HIV knowledge and sexual risk behavior and condom use efficacy in a sample of 122 at-risk females, aged 13–18. HIV knowledge was unrelated to sexual risk behavior, but positively related to condom use efficacy. Impulsivity and childhood adversity had direct effects, with no interaction effects. Increasing HIV knowledge may play an important role in promoting proximal predictors of safer sex practices.


2020 ◽  
Author(s):  
Erwan Sallard ◽  
François-Xavier Lescure ◽  
Charles Burdet ◽  
Jérémie Guedj ◽  
Yazdan Yazdanpanah ◽  
...  

AbstractIntroductionEfficient therapeutic strategies are needed to counter the COVID-19 pandemic, caused by the SARSCoV-2 virus. In a context where specific vaccines are not yet available, the containment of the pandemic would be facilitated with efficient prophylaxis.MethodsWe screened several clinical trials repositories and platforms in search of the prophylactic strategies that are investigated against COVID-19 in late April 2020.ResultsUp to April 27, 2020, we found 68 clinical trials targeting medical workers (n = 43, 63%), patients relatives (n = 16, 24%) or individuals at risk of severe COVID-19 (n = 5, 7%). (Hydroxy)chloroquine was the most frequently evaluated treatment (n = 46, 68%), before BCG vaccine (n = 5, 7%). Sixty-one (90%) clinical trials were randomized with a median of planned inclusions of 600 (IQR 255–1515).ConclusionThe investigated prophylaxis strategies cover both pre- and post-exposure prophylaxis and study numerous immune enhancers and antivirals, although most research efforts are focused on (hydroxy)chloroquine.


Sign in / Sign up

Export Citation Format

Share Document